A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
CEA
MessageChemistry
Test Code
LAB57
Alias/See Also
Carcinoembryonic Antigen
CPT Codes
82378
Includes
Carcinoembryonic Antigen
Preferred Specimen
Gold top (serum separator tube)
Minimum Volume
Whole blood: 600 uL ( one full light-green-top microtainer or two full red-top microtainers).
Serum/plasma: 300 uL plasma.
Other Acceptable Specimens
Red Top and Light green top (lithium heparin plasma) acceptable
Specimen Stability
Serum and plasma samples
Refrigerated: 7 days
Frozen: 4 weeks
Refrigerated: 7 days
Frozen: 4 weeks
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolyzed, contaminated, not enough volume
FDA Status
Approved
Setup Schedule
Everyday
Report Available
Same day
Limitations
The VITROS CEA test is not recommended as a screening procedure for cancer detection.
The results from this or any other diagnostic test should be used and interpreted only in the context of the
overall clinical picture.
Different CEA test methods cannot be used interchangeably. CEA in a given patient sample determined
with tests from different manufacturers can vary due to differences in test methods and reagent
specificity. A change to the test used during serial monitoring of a patient should be accompanied by
additional sequential testing to confirm baseline values.
The results from this or any other diagnostic test should be used and interpreted only in the context of the
overall clinical picture.
Different CEA test methods cannot be used interchangeably. CEA in a given patient sample determined
with tests from different manufacturers can vary due to differences in test methods and reagent
specificity. A change to the test used during serial monitoring of a patient should be accompanied by
additional sequential testing to confirm baseline values.
Reference Range
0.0 - 3.0 ng/ml
Clinical Significance
This immunoassay is manufactured by Ortho clinical Diagnostics. Tumor marker values using different test methods or manufacturers may vary and cannot be compared. If there is a change to the manufacturer or methodology, patients undergoing serial monitoring should have additional testing performed to confirm baseline values.
Performing Laboratory
Hoag Newport